Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine
The Journal of Clinical Endocrinology & Metabolism · 18.10.2023 · 108 (11) · e1193-e1198
DOI: 10.1210/clinem/dgad298 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.06.2023. Verfasst von Cyrus V Desouza und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, Asahi Kasei Pharma Corporation.
Abstract (Originalsprache)
Context
Intermediate-term glycemic control metrics may represent a viable alternative to continuous glucose monitoring (CGM) in patients without access to CGM.
Objective
This work aimed to compare the relationship between CGM parameters and glycated albumin (GA), glycated hemoglobin A1c (HbA1c), and fructosamine for 24 weeks.
Methods
We conducted exploratory comparative analyses of CGM subgroup data from a previously published 24-week prospective study of assay performance in 8 US clinics. Participants included 34 individuals with type 1 (n = 18) and type 2 diabetes (n = 16) undergoing changes to improve glycemic control (n = 22; group 1) or with stable diabetes therapy (n = 12; group 2). Main outcome measures included Pearson correlations between CGM and glycemic indices and receiver operating characteristic (ROC) analysis of glycemic index values predictive of time in range (TIR) greater than 70%.
Results
At weeks 4 and 8, GA correlations with TIR were higher than HbA1c correlations in group 1. In group 2, GA correlations with TIR were statistically significant, whereas HbA1c correlations were not. In both groups over the first 12 weeks, GA correlations with TIR were higher than fructosamine-TIR correlations. In the ROC analysis, GA predicted a TIR greater than 70% during weeks 2 to 24 (area under the curve >0.80); HbA1c was predictive during weeks 12 to 24. Cutoff values for TIR greater than 70% were 17.5% (sensitivity and specificity, 0.88) for GA and 7.3% (0.86) for HbA1c.
Conclusion
GA is the most accurate predictor of TIR over 8 weeks compared with other glycemic indices, which may assist in clinical evaluation of changes in treatment where CGM is not possible and it is too early to use HbA1c (NCT02489773).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.
- Velocity Clinical Research at Medical City, Dallas, TX 75230, USA.
- Research and Development Department, Asahi Kasei Pharma, Tokyo 100-0006, Japan.
- Section of Endocrinology, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.
ORCID-Profile: Cyrus V Desouza, Julio Rosenstock, Takuji Kohzuma, Vivian A Fonseca
Förderung
- NIGMS NIH HHS
- Asahi Kasei Pharma Corporation
Zitieren
APA
Desouza, C. V., Rosenstock, J., Kohzuma, T., & Fonseca, V. A. (2023). Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine. The Journal of Clinical Endocrinology & Metabolism, 108(11), e1193-e1198. https://doi.org/10.1210/clinem/dgad298
Vancouver
Desouza CV, Rosenstock J, Kohzuma T, Fonseca VA. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine. The Journal of Clinical Endocrinology & Metabolism. 2023;108(11):e1193-e1198. doi:10.1210/clinem/dgad298
BibTeX
@article{Desouza2023,
author = {Desouza, Cyrus V and Rosenstock, Julio and Kohzuma, Takuji and Fonseca, Vivian A},
title = {Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {11},
pages = {e1193--e1198},
doi = {10.1210/clinem/dgad298}
}
EUVIMED